文献速递毛发、甲与色素性疾病

白癜风患者的血清同型半胱氨酸、叶酸和维生素B12水平及其作为疾病活动性生物标志物的潜在作用:系统综述与Meta分析

Serum homocysteine, folate, and vitamin B12 levels in patients with vitiligo and their potential roles as disease activity biomarkers: A systematic review and meta-analysis.
PubMed 文献 · J Am Acad Dermatol · 2018-08-28

该系统综述与Meta分析检索2018年5月15日的在线数据库,纳入22项研究共1448例白癜风患者,比较其与对照的血清同型半胱氨酸、叶酸和维生素B12水平。结果显示白癜风患者血清同型半胱氨酸显著高于对照(SMD 0.550,95%CI 0.262-0.838;I² 87.3%),维生素B12显著低于对照(SMD -0.430,95%CI -0.738至-0.121;I² 85.3%),叶酸无显著差异(SMD -0.240,95%CI -0.592至0.111;I² 85.5%);亚组分析提示这些发现与疾病活动性相关。

要点

  • 白癜风患者血清同型半胱氨酸显著高于对照,SMD 0.550(95%CI 0.262-0.838)。
  • 白癜风患者血清维生素B12显著低于对照,SMD -0.430(95%CI -0.738至-0.121)。
  • 血清叶酸两组无显著差异,SMD -0.240(95%CI -0.592至0.111)。

核心结论

  • 白癜风患者血清同型半胱氨酸水平高于无白癜风个体,血清维生素B12水平低于无白癜风个体。

研究设计与样本

  • 系统综述与Meta分析,检索2018年5月15日的在线数据库,纳入比较白癜风患者与对照血清同型半胱氨酸、叶酸和维生素B12水平的研究,共22项研究、1448例白癜风患者,采用随机效应模型。

主要发现

  • 白癜风患者血清同型半胱氨酸显著高于对照,SMD 0.550(95%CI 0.262-0.838;I² 87.3%)。
  • 白癜风患者血清维生素B12显著低于对照,SMD -0.430(95%CI -0.738至-0.121;I² 85.3%)。
  • 血清叶酸两组无显著差异,SMD -0.240(95%CI -0.592至0.111;I² 85.5%)。
  • 亚组分析显示这些发现与疾病活动性相关。

局限性

  • 纳入的研究存在异质性。
  • 血清同型半胱氨酸水平可能受多种因素影响。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Hyperhomocysteinemia and folate and vitamin B12 deficiencies have been reported in patients with vitiligo. Investigating the role of these conditions might shed light on the pathogenesis of vitiligo. OBJECTIVE: To perform a systematic review and meta-analysis of studies assessing serum homocysteine, folate, and vitamin B12 levels in vitiligo patients. METHODS: Online databases were searched on May 15, 2018, to identify studies comparing serum homocysteine, folate, and vitamin B12 levels between patients with vitiligo and controls. A random effects model was used. RESULTS: Twenty-two studies involving a total of 1448 patients with vitiligo were included. Patients with vitiligo had significantly higher serum homocysteine levels (standardized mean difference [SMD] 0.550, 95% confidence interval [CI] 0.262-0.838; I2 87.3%) and lower vitamin B12 levels (SMD -0.430, 95% CI -0.738 to -0.121; I2 85.3%) than controls. Serum folate levels were not significantly different between the 2 groups (SMD -0.240, 95% CI -0.592 to 0.111; I2 85.5%). A subgroup analysis revealed that these findings correlated with disease activity. LIMITATIONS: The included studies were heterogeneous. Serum homocysteine levels could be influenced by various factors. CONCLUSION: Patients with vitiligo have higher serum homocysteine levels and lower vitamin B12 levels than individuals without vitiligo.

来源:J Am Acad Dermatol,查看原文。版权归原作者所有。

引用

  1. Tsai TY, Kuo CY, Huang YC, et al. Serum homocysteine, folate, and vitamin B12 levels in patients with vitiligo and their potential roles as disease activity biomarkers: A systematic review and meta-analysis. J Am Acad Dermatol. 2018. PMID: 30165163. doi:10.1016/j.jaad.2018.08.029

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。